FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of molecular biology and genetic engineering. Claimed are: a method and a set for the detection of poorly represented RNA fractions in a biological sample and for the detection of mycoplasma contamination, for which purpose used are operations of reverse transcription of RNA into cDNA with the application of reverse transcriptase Thermus thermophilus (rTth-pol) under conditions of "hot start", RT inactivation by processing with a chaotropic preparation, detection of cDNA of interest by a polymerase chain reaction (PCR).
EFFECT: invention can be used in medicine in testing for the mycoplasma presence.
15 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIATING Mycoplasma hominis BACTERIA STRAINS ACCORDING TO RIBOSOMAL RNA GENE | 2008 |
|
RU2386699C2 |
| METHOD OF DIFFERENTIATING BACTERIA STRAINS ACCORDING TO RIBOSOMAL RNA GENE | 2008 |
|
RU2386695C1 |
| METHOD OF DETECTION OF MICROORGANISMS BELONGING TO SPECIES OF MYCOPLASMA PNEUMONIAE MIND AND/OR MYCOPLASMA GENITALIUM | 2010 |
|
RU2575075C2 |
| METHOD OF MICROORGANISM DETECTION IN BIOLOGICAL SAMPLE | 2007 |
|
RU2435865C2 |
| METHOD OF QUANTITATIVE ANALYSIS OF CELL NUMBER OF ALIVE BACTERIUM OF INTEREST WITH APPLYING rRNA AS TARGET | 2006 |
|
RU2420595C2 |
| METHOD FOR TARGET AMPLIFICATION OF HUMAN REPRODUCTIVE ORGANS INFECTORS GENOMES FOR SIMULTANEOUS IDENTIFICATION OF INFECTORS WITH PRIMER SET | 2015 |
|
RU2625006C1 |
| METHOD FOR MYCOPLASMA HOMINIS DNA DETECTION FROM BLOOD SAMPLES | 2013 |
|
RU2533238C1 |
| METHOD FOR DETECTING THE PRESENCE OF MUTATIONS LEADING TO MYCOPLASMA GENITALIUM RESISTANCE TO MACROLIDE AND FLUOROQUINOLONE ANTIBIOTICS | 2019 |
|
RU2725477C1 |
| METHODS, SYSTEMS AND COMPOSITIONS FOR MICROBIAL DNA DETECTION BY PCR | 2012 |
|
RU2620953C2 |
| METHOD FOR MEDIATED DETERMINATION OF TITRE OF INFECTIOUS ACTIVITY OF MYCOPLASMA GALLISEPTICUM BY PCR IN REAL TIME MODE | 2023 |
|
RU2823778C1 |
